SEARCH

SEARCH BY CITATION

References

  • 1
    Thrift FA, Overfield JR. Impact of pinkeye (infectious bovine kerato-conjunctivitis) on weaning and postweaning performance of Hereford calves. J Anim Sci 1974;38:11791184.
  • 2
    Brown MH, Brightman AH, Fenwick BW, et al. Infectious bovine keratoconjunctivitis: A review. J Vet Intern Med 1998; 12:259266.
  • 3
    Funk L, O'Connor AM, Maroney M, et al. A randomized and blinded field trial to assess the efficacy of an autogenous vaccine to prevent naturally occurring infectious bovine keratoconjunctivis (IBK) in beef calves. Vaccine 2009;27:45854590.
  • 4
    Burns MJ, O'Connor AM. Assessment of methodological quality and sources of variation in the magnitude of vaccine efficacy: A systematic review of studies from 1960 to 2005 reporting immunization with Moraxella bovis vaccines in young cattle. Vaccine 2008;26:144152.
  • 5
    Arora AK, Killinger AH, Mansfield ME. Bacteriologic and vaccination studies in a field epizootic of infectious bovine keratoconjunctivitis in calves. Am J Vet Res 1976;37:803805.
  • 6
    Davidson HJ, Stokka GL. A field trial of autogenous Moraxella bovis bacterin administered through either subcutaneous or subconjunctival injection on the development of keratoconjunctivitis in a beef herd. Can Vet J 2003; 44:577580.
  • 7
    Hughes DE, Kohlmeier RH, Pugh GW Jr, et al. Comparison of vaccination and treatment in controlling naturally occurring infectious bovine keratoconjunctivitis. Am J Vet Res 1979; 40:241244.
  • 8
    Hughes DE, Pugh GW Jr, Kohlmeier RH, et al. Effects of vaccination with a Moraxella bovis bacterin on the subsequent development of signs of corneal disease and infection with M. bovis in calves under natural environmental conditions. Am J Vet Res 1976; 37:12911295.
  • 9
    Shen HG, Gould S, Kinyon J, et al. Development and evaluation of a multiplex real-time PCR assay for detection and differentiation of Moraxella bovis, Moraxella bovoculi and Moraxella ovis in pure culture isolates and lacrimal swabs collected from conventional raised cattle. J Appl Microbiol 2011; Aug 9. doi: 10.1111/j.1365-2672.2011.05123.x. [Epub ahead of print].
  • 10
    Billingsley P. Probability and Measure, 2nd ed. New York: John Wiley & Sons, Inc; 1986.
  • 11
    Angelos JA, Bonifacio RG, Ball LM, et al. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine. Vet Microbiol 2007;125:274283.
  • 12
    Tizard I. Veterinary Immunology, 8th ed. St. Louis, MO: Saunders Elsevier; 2009.
  • 13
    Lehr C, Jayappa HG, Goodnow RA. Serologic and protective characterization of Moraxella bovis pili. Cornell Vet 1985; 75:484492.
  • 14
    McConnel CS, House JK. Infectious bovine keratoconjunctivitis vaccine development. Aust Vet J 2005;83:506510.